| 朱伟明,王文玲,王立平,等.珊瑚真菌Aspergillus sp. OUCMDZ-3658产生的生物碱[J].中国海洋药物,2015,34(6):1-11. |
| 珊瑚真菌Aspergillus sp. OUCMDZ-3658产生的生物碱 |
| Alkaloids from Aspergillus sp. OUCMDZ-3658 associated with soft coral |
| 投稿时间：2015-04-17 修订日期：2015-04-29 |
| DOI： |
| 中文关键词: 珊瑚真菌，活性产物，生物碱，α-糖苷酶抑制 |
| English Keywords:coral fungi bioactive natural products alkaloids α-glucosidase inhibition |
| Fund Project: |
|
| 摘要点击次数: 7908 |
| 全文下载次数: 1773 |
| 中文摘要: |
| 目的 探究来源于西沙群岛的珊瑚真菌Aspergillus sp. OUCMDZ-3658的活性天然产物。方法 利用柱色谱及高效液相色谱等手段对发酵产物进行分离、纯化，运用质谱、核磁共振、圆二色谱和比旋光等方法鉴定化合物的结构，采用MTT法、药敏纸片法和α-糖苷酶抑制评价化合物的生物活性。结果 从珊瑚真菌OUCMDZ-3658的发酵产物中分离获得了13个生物碱(1-13)和1个fusidane型三萜(14)，其结构依次鉴定为fumiquinazolines A (1)和C (2)、fumiquinazolines D (3)和F (4)、chaetominine (5)、pseurotins A1 (6)和A2 (7)、fumitremorgin C (8)、cyclouyprostatin A (9)、12β-hydroxy-13α-methoxyverruculogen TR-2 (10)、9H-pyrido[3,4-b] indole-3-carboxylic acid (11)、(–)-cyclopenol (12)、pyripyropene A (13)以及烟曲霉酸helvolic acid (14)。化合物8和9对产气杆菌、化合物10对白色念珠菌有弱抑制活性，MIC值分别为33.0、30.4和56.4 μmol/L；化合物3和4对α-糖苷酶有抑制作用，活性与阳性药阿卡波糖相当，IC50值分别为0.87、1.14和 1.11 mmol/L）。结论 本文首次报道了fumiquinazolines D (3)和F (4)的α-糖苷酶抑制活性，为α-糖苷酶抑制剂的发现提供了新的结构类型。 |
| English Summary: |
| Objective To identify the active secondary metabolites of the coral fungus Aspergillus sp. OUCMDZ-3658 from XiSha Islands. Methods The isolations and purifications of compounds were performed by means of solvent extraction, column chromatography over silica gel, Sephadex LH-20 and HPLC. And their structures were elucidated through the analysis of MS, NMR, [α]D and CD. The bioactivities were assayed by MTT, paper diffusion and the α-glucosidase inhibition methods. Results From the cultures of Aspergillus sp. OUCMDZ-3658, we isolated thirteen alkaloids (1-13) and a fusidane-type triterpenoid (14). Their structures were identified as fumiquinazolines A (1) and C (2), fumiquinazolines D (3) and F (4), chaetominine (5), pseurotins A1 (6) and A2 (7), fumitremorgin C (8), cyclouyprostatin A (9), 12β-hydroxy-13α-methoxyverruculogen TR-2 (10), 9H-pyrido[3,4-b]indole-3-carboxylic acid (11), (–)-cyclopenol (12), pyripyropene A (13) and helvolic acid (14), respectively. Compounds 8 and 9 showed weak antibacterial activity against Enterobacter aerogenes while compound 10 showed weak antifungal activity against Candida albican with MIC values of 33.0, 30.4 and 56.4 μmol/L, respectively. Compounds 3 and 4 displayed comparable α-glucosidase inhibition to acarbose (positive control) with the IC50 values of 0.87, 1.14 and 1.11 mmol/L, respectively. Conclusion This paper reported the α-glucosidase inhibition of fumiquinazolines D (3) and F (4) for the first time and thus afforded the new structure-type for screening of α-glucosidase inhibitors. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
|
|
|